Schedule 13G ownership disclosure
Intec Pharma Ltd.
Security class unavailable · CUSIP: M53644106
Event date: 2017-03-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 851,777
- Percent of class
- 6.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-17-006213
- Form type
- SC 13G
- Filer
- AYALIM MUTUAL FUNDS LTD
- CIK
- CIK 1705142
- Filed
- Jun 07, 2017
- Reporting period
- Mar 23, 2017
- Description
- Schedule 13G beneficial ownership